María E. Rodríguez-Ruiz

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

Álvaro Teijeira, Saray Garasa, María Gato et al. · Immunity · 2020 · 718 citations · Full text

Inflammation, Cytokine, Immune Cytotoxicity +8

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

Kurt A. Schalper, María E. Rodríguez-Ruiz, Ricardo Díez-Valle et al. · Nature Medicine · 2019 · 642 citations

Neuro-oncology, Cancer Immunosurveillance, Medicine +11

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

Elísabeth Pérez-Ruiz, Luna Minute, Itziar Otano et al. · Nature · 2019 · 465 citations · Full text

Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti–PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells

Alfonso R. Sánchez-Paulete, Francisco J. Cueto, María Martínez‐López et al. · Cancer Discovery · 2015 · 461 citations · Full text

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients

Miguel F. Sanmamed, José Luis Perez‐Gracia, Kurt A. Schalper et al. · Annals of Oncology · 2017 · 442 citations · Full text

Cancer Immunosurveillance, Anti-pd-1 Treatment, Medicine +8